ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 52 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $16,000 | -84.3% | 12,777 | -84.8% | 0.00% | -100.0% |
| Q2 2020 | $102,000 | +21.4% | 84,329 | +113.0% | 0.00% | – |
| Q4 2019 | $84,000 | +47.4% | 39,588 | +140.9% | 0.00% | -100.0% |
| Q1 2019 | $57,000 | +72.7% | 16,433 | +1.4% | 0.00% | 0.0% |
| Q4 2017 | $33,000 | -81.8% | 16,200 | -58.9% | 0.00% | -66.7% |
| Q3 2017 | $181,000 | +39.2% | 39,375 | +16.5% | 0.00% | -78.6% |
| Q4 2015 | $130,000 | – | 33,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |